Novartis to Buy U.S.-Based Chinook
Wall Street Journal
Novartis has agreed to acquire Chinook Therapeutics for up to $3.5 billion, in a deal that will expand its portfolio of kidney disease treatments.
https://www.wsj.com/articles/novartis-to-acquire-chinook-therapeutics-for-up-to-3-5-billion-c9607248